Statistics

Total Visits

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study57

File Visits

Downloads
41131-1808.pdf12

Select a period of time:

Number of views in the range

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study34

Number of downloads in the range

Downloads
41131-1808.pdf2

Views

Views
April 202511
May 20253
June 20250
July 202515
August 20251
September 20253
October 20251
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • April 2025
    1
  • May 2025
    0
  • June 2025
    0
  • July 2025
    0
  • August 2025
    1
  • September 2025
    0
  • October 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong10
Brazil10
United States7
Argentina1
Spain1
Ethiopia1
United Kingdom1
Ireland1
Mexico1
Turkey1
 

Top countries by downloads

Downloads
Hong Kong1
United States1
 

Top cities views

Views
Hong Kong10
Atlanta1
Belo Horizonte1
Belém1
Brasília1
Caxambu1
Caxias do Sul1
Conceição do Coité1
Council Bluffs1
Dublin1
 

Top cities by downloads

Downloads
Hong Kong1